The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells - Asl, Maryam Soltani; Sorkhabi, Parviz Azimnasab; Yoshinaga, Túlio Teruo; Gomes, Cristina de Oliveira Massoco-Salles; Kfoury Junior, José Roberto (Immunologic Research, 2023)